Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 2
2009 1
2010 7
2011 2
2012 3
2013 3
2014 3
2016 7
2017 10
2018 10
2019 9
2020 23
2021 20
2022 10
2023 11
2024 14
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate : A Cross-sectional Analysis of Pooled Data.
Pottel H, Björk J, Courbebaisse M, Couzi L, Ebert N, Eriksen BO, Dalton RN, Dubourg L, Gaillard F, Garrouste C, Grubb A, Jacquemont L, Hansson M, Kamar N, Lamb EJ, Legendre C, Littmann K, Mariat C, Melsom T, Rostaing L, Rule AD, Schaeffner E, Sundin PO, Turner S, Bökenkamp A, Berg U, Åsling-Monemi K, Selistre L, Åkesson A, Larsson A, Nyman U, Delanaye P. Pottel H, et al. Among authors: garrouste c. Ann Intern Med. 2021 Feb;174(2):183-191. doi: 10.7326/M20-4366. Epub 2020 Nov 10. Ann Intern Med. 2021. PMID: 33166224 Free article.
Spondyloarthritis-Associated IgA Nephropathy.
Champtiaux N, Lioté F, El Karoui K, Vigneau C, Miceli C, Cornec-Le Gall E, Rémy P, Choukroun G, Fakhouri F, Garrouste C, Veillon L, Pillebout E, Lobbedez T, Vuiblet V, Wynckel A, Guincestre T, Toussirot E, Thervet E, Rabant M, Karras A. Champtiaux N, et al. Among authors: garrouste c. Kidney Int Rep. 2020 Mar 16;5(6):813-820. doi: 10.1016/j.ekir.2020.03.012. eCollection 2020 Jun. Kidney Int Rep. 2020. PMID: 32518863 Free PMC article.
Estimating glomerular filtration in young people.
Delanaye P, Derain-Dubourg L, Björk J, Courbebaisse M, Couzi L, Gaillard F, Garrouste C, Grubb A, Jacquemont L, Hansson M, Kamar N, Legendre C, Littmann K, Mariat C, Rostaing L, Rule AD, Sundin PO, Bökenkamp A, Berg U, Åsling-Monemi K, Åkesson A, Larsson A, Nyman U, Pottel H. Delanaye P, et al. Among authors: garrouste c. Clin Kidney J. 2024 Aug 28;17(9):sfae261. doi: 10.1093/ckj/sfae261. eCollection 2024 Sep. Clin Kidney J. 2024. PMID: 39314869 Free PMC article.
Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study.
Lortholary O, Garcia-Hermoso D, Sturny-Leclère A, Sitbon K, Nourrisson C, Letscher-Bru V, Desbois-Nogard N, Bani-Sadr F, Bastides F, Bienvenu B, Cordier C, Coste A, Danion F, Dégot T, Delarbre D, Fekkar A, Garcie C, Garrouste C, Gits-Muselli M, Guemas E, Huguenin A, Janvier F, Kamar N, Kervinio C, Le Gal S, Lesens O, Machouart M, Persat F, Picot S, Rouze A, Ranque S, Ruch Y, Saada M, Stabler S, Alanio A, Lanternier F, Desoubeaux G. Lortholary O, et al. Among authors: garrouste c. Lancet Microbe. 2024 Nov;5(11):100907. doi: 10.1016/S2666-5247(24)00139-3. Epub 2024 Oct 9. Lancet Microbe. 2024. PMID: 39395429 Free article.
128 results